| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |